Records containing: Pulmonary Arterial Hypertension
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-01-12Phase 2 Open-Label Study of Safety and Efficacy Trial of CXA-10 in Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2021-12-22An Open-label Extension Study of Ralinepag in Patients With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2021-12-09Pharmacogenomics in Pulmonary Arterial Hypertension: A Multi-Center International Study to Determine Whether in PAH Patients Clinical Associations Exist Between the Efficacy and Toxicity of Endothelin Receptor Antagonists and Several Gene Polymorphisms in Several Key Disease-Specific and Therapy Specific Genes
-
CLINICAL_TRIALS study record update · 2021-11-22Assessment of the TGF-beta Pathway and Micro-RNA in Pediatric Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2021-11-15Novel Screening Strategies for Scleroderma PAH (Pulmonary Arterial Hypertension)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-11-02The Expression and Significance of miRNA Profile and Markers of Inflammation in Patients With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2021-10-11The International Stress Echo Study in Ischemic and Non-ischemic Heart Disease
-
CLINICAL_TRIALS study record update · 2021-09-13A Two Part, Phase 2 Open-label, Multi-Centre, Dose Escalation Hemodynamic Study to Evaluate Dose-Response and Safety of Inhaled LIQ861 (Treprostinil) in Pulmonary Arterial Hypertension (WHO Group 1) Subjects
-
CLINICAL_TRIALS study record update · 2021-09-08Volatile Organic Compounds as a Biomarker in Immune-mediated Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2021-09-01A Phase 1, Placebo-Controlled, Double-Blind, Dose-Escalation Study To Investigate The Safety, Tolerability, And Pharmacokinetics Of A Single Intravenous Dose Of GMA301 Injection In Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2021-09-01A Phase 1b, Randomized, Subject- and Investigator-Blinded, Placebo-Controlled, Multi-Center Clinical Trial to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Biomarkers of Inhaled GB002 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
-
CLINICAL_TRIALS study record update · 2021-08-19Assessment of Safety and Efficacy of Implantable Pump (LenusPro) in Patients With Pulmonary Arterial Hypertension Treated With Treprostinil.
-
CLINICAL_TRIALS study record update · 2021-08-06An Open-label, Three Period, Fixed Sequence Study to Assess the Effect of a Single Dose of BIA 5 1058 400 mg on Warfarin Pharmacokinetics in Healthy Subjects Under Fasting Conditions
-
CLINICAL_TRIALS study record update · 2021-08-06An Open-Label, Three Period, Fixed Sequence Study to Assess the Effect of a Single Dose of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Sildenafil in Healthy Subjects Under Fasting Conditions
-
CLINICAL_TRIALS study record update · 2021-08-05An Open-label, Three Period, Fixed Sequence Study to Assess the Effect of a Single Dose of BIA 5 1058 400 mg on the Steady State Pharmacokinetics of Bosentan in Healthy Subjects Under Fasting Conditions
-
CLINICAL_TRIALS study record update · 2021-08-05Effect of Age-gender on the Pharmacokinetic and Pharmacodynamic Profiles of BIA 5 1058. An Open-label, Parallel Group, Multiple Dose 10-day Study.
-
CLINICAL_TRIALS study record update · 2021-08-05Effect of Food on BIA 5-1058 Bioavailability in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2021-08-05An Open-label Study to Assess the Absorption, Distribution, Metabolism and Excretion, Including the Mass Balance, of [14C] Labeled BIA 5-1058 and Metabolites Following a Single Oral Dose Administration in Healthy Male Subjects
-
CLINICAL_TRIALS study record update · 2021-07-23A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
-
CLINICAL_TRIALS study record update · 2021-07-14CLinical Epigenetic-sensitive trajectOries Underlying Pulmonary Arterial Hypertension and neTwoRk Analysis (CLEOPAHTRA)
-
CLINICAL_TRIALS study record update · 2021-07-02Implantable System for Remodulin Post-Approval Study
-
CLINICAL_TRIALS study record update · 2021-06-24A Mobile Health Intervention in Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2021-06-21A Non-Randomized, Multiple Dose, Three Treatment Period, Open-Label, Single Sequence, Single Group Study to Evaluate the Pharmacokinetic Effect of Two Doses of QTI571 (Imatinib) on the Co-administered Drugs Sildenafil and Bosentan in Pulmonary Arterial Hypertension (PAH) Patients
-
CLINICAL_TRIALS study record update · 2021-06-18Prevalence of Musculoskeletal Pain and Its Impact on Quality of Life and Functional Exercise Capacity in Patients With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2021-05-18[18F]Fluoroestradiol (FES) PET/CT Imaging To Evaluate In Vivo ER In Patients With Pulmonary Arterial Hypertension (PAH)